Our Protocols are proprietary ownership may be disclosed only and solemnly on signature of Nondisclosure Agreement NDA, our Contractual Agreement and payment of Contractual Cost

We believe that addressing the unique challenges of stem-cell clinical research provides an important pathway for ensuring that safe, effective stem-cell therapies are readily available to patients in need and for building the scientific foundation for further advances

Stem Cell Therapeutic Strategies employ the novel use of cells, biomaterials and procedures to address complex trauma to vasculature, nerves, bones, cartilage and muscle

OUR SVF DEPLOYMENT PROTOCOLS

Our team members have been involved for the last 10 years in the development and utilization of Stromal Vascular Fraction SVF stem cell based clinical IRB-approved and Proprietary Protocols related to malignant and non-malignant disorders